Manulife (Manufacturers Life Insurance)’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-20,385
| Closed | -$65K | – | 3040 |
|
2022
Q1 | $65K | Sell |
20,385
-5,076
| -20% | -$16.2K | ﹤0.01% | 3017 |
|
2021
Q4 | $107 | Buy |
25,461
+639
| +3% | +$3 | ﹤0.01% | 3043 |
|
2021
Q3 | $202K | Sell |
24,822
-2,286
| -8% | -$18.6K | ﹤0.01% | 2978 |
|
2021
Q2 | $205K | Buy |
27,108
+1,156
| +4% | +$8.74K | ﹤0.01% | 3086 |
|
2021
Q1 | $225K | Sell |
25,952
-645
| -2% | -$5.59K | ﹤0.01% | 2823 |
|
2020
Q4 | $212K | Buy |
26,597
+2,852
| +12% | +$22.7K | ﹤0.01% | 2741 |
|
2020
Q3 | $189K | Buy |
23,745
+2,468
| +12% | +$19.6K | ﹤0.01% | 2592 |
|
2020
Q2 | $208K | Sell |
21,277
-113
| -0.5% | -$1.11K | ﹤0.01% | 2478 |
|
2020
Q1 | $165K | Buy |
21,390
+204
| +1% | +$1.57K | ﹤0.01% | 2408 |
|
2019
Q4 | $82K | Sell |
21,186
-691
| -3% | -$2.68K | ﹤0.01% | 2825 |
|
2019
Q3 | $111K | Buy |
21,877
+989
| +5% | +$5.02K | ﹤0.01% | 2804 |
|
2019
Q2 | $138K | Buy |
20,888
+9,748
| +88% | +$64.4K | ﹤0.01% | 2803 |
|
2019
Q1 | $84K | Buy |
11,140
+1,135
| +11% | +$8.56K | ﹤0.01% | 2598 |
|
2018
Q4 | $81K | Sell |
10,005
-806
| -7% | -$6.53K | ﹤0.01% | 2457 |
|
2018
Q3 | $139K | Sell |
10,811
-11,354
| -51% | -$146K | ﹤0.01% | 2850 |
|
2018
Q2 | $253K | Buy |
22,165
+21,795
| +5,891% | +$249K | ﹤0.01% | 2932 |
|
2018
Q1 | $3K | Sell |
370
-891
| -71% | -$7.22K | ﹤0.01% | 4190 |
|
2017
Q4 | $8K | Buy |
+1,261
| New | +$8K | ﹤0.01% | 4032 |
|
2017
Q3 | – | Sell |
-1,600
| Closed | -$7K | – | 4249 |
|
2017
Q2 | $7K | Sell |
1,600
-180
| -10% | -$788 | ﹤0.01% | 3853 |
|
2017
Q1 | $8K | Sell |
1,780
-384
| -18% | -$1.73K | ﹤0.01% | 3678 |
|
2016
Q4 | $12K | Buy |
2,164
+180
| +9% | +$998 | ﹤0.01% | 3724 |
|
2016
Q3 | $13K | Buy |
1,984
+1,000
| +102% | +$6.55K | ﹤0.01% | 3634 |
|
2016
Q2 | $4K | Buy |
+984
| New | +$4K | ﹤0.01% | 3854 |
|